In China, chronic hepatitis B remains a major public health challenge, affecting tens of millions of people. 😖 For patients who require long-term antiviral therapy,

As global demographic shifts, evolving disease landscapes, and rising expectations for treatment experience continue to reshape healthcare, the pharmaceutical industry is facing unprecedented opportunities and

In the field of oncology, relapsed or refractory peripheral T-cell lymphoma (PTCL) and endocrine therapy resistance in HR-positive advanced breast cancer remain two major clinical

The treatment of advanced gastrointestinal stromal tumors (GIST) is a long and arduous race against genetic mutations. 💊 Patients typically follow a standard sequential treatment

In the field of HIV antiviral therapy, “simplification” and “potency” have long been the two enduring goals that define the gold standard in HIV treatment.